Skip to content

Generation of Thrombin and Prediction of Deep Vein Thrombosis Post Prosthetic Orthopedic Surgery of the Lower Limbs

Generation of Thrombin and Prediction of Deep Vein Thrombosis Post Prosthetic Orthopedic Surgery of the Lower Limbs

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03634124
Acronym
GT-PT
Enrollment
146
Registered
2018-08-16
Start date
2019-02-21
Completion date
2023-10-17
Last updated
2026-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Vein Thrombosis, Knee Prosthesis, Total Hip Prosthesis

Brief summary

The numerical ratio between the value of the thrombin generation test performed without soluble thrombomodulin and the value of the thrombin generation test performed in the presence of soluble thrombomodulin, performed pre-surgically, could predict the risk of early venous thromboembolism after placement of total hip or knee prosthesis.

Interventions

BIOLOGICALBlood test

Additional blood test of 4,5 ml of venous blood

OTHERDoppler ultrasound

Vascular ultrasonic vascular exploration of the lower limbs

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient must have his consent and signed the consent form. * The patient must affiliated or a beneficiary of a health insurance plan. * The patient is at least 18 years old * Patient with an indication of total hip prosthesis or total knee replacement surgery set unilateral

Exclusion criteria

* The patient is participating in another interventional study. * The patient is in an exclusion period determined by a previous study. * Minor patients, people in emergency situations. * The patient is under the protection of justice, guardianship or curatorship. * The patient refuses to sign the consent. * It is not possible to inform the patient. * The patient is pregnant, parturient, or breastfeeding. * The patient has a contraindication (or incompatible drug combination) to drug thromboprophylaxis applied according to good clinical practice and recommendations of learned societies * Long-term anticoagulant therapy for personal thrombotic history. * Known hemorrhagic disease. * Haemorrhagic risk perceived during the consultation of preoperative anesthesia, leading to modify / develop the usual thromboprophylaxis. * Chronic liver disease. * Chronic renal failure with calculated clearance \<30 ml / min. * Extreme body mass index: \<18 kg.m-2 or\> 40 kg.m-2 * total hip prosthesis or total knee prosthesis in the immediate aftermath of a bone fracture. * total hip prosthesis resumption. * Installation of more than one joint prosthesis. * Surgery in the previous 3 months. * Infective push in the previous 3 months. * Indication of haemostatic treatment for abnormal haemorrhagic risk. * Severe impairment of renal function with a calculated clearance \<30 ml / min. * Contraindication (allergic, metabolic, other ...) to usual drug thromboprophylaxis. * Condition requiring dosage adjustment of drug thromboprophylaxis. * Indication to put in place intermittent pneumatic compression for perioperative thromboprophylaxis.

Design outcomes

Primary

MeasureTime frameDescription
Estimate the numerical ratio between the value of the thrombin generation test performed without soluble thrombomodulin and the value of the thrombin generation test performed in the presence of soluble thrombomodulinDay 0Numerical value
Occurrence of Symptomatic pulmonary embolismDay 7 (± 2)yes/non
Occurrence of Symptomatic deep vein thrombosis somewhere in the bodyDay 7 (± 2)Yes/no
Occurrence of Symptomatic deep vein thrombosis in legsDay 7 (± 2)Yes/non

Secondary

MeasureTime frameDescription
Occurrence of proximal Symptomatic deep vein thrombosis in legsDay 7 (± 2)Yes/no
Occurrence of distal Symptomatic deep vein thrombosis in legsDay 7 (± 2)Yes/no
Occurrence of muscular Symptomatic deep vein thrombosis in legsDay 7 (± 2)Yes/no
Occurrence of any kind of Symptomatic deep vein thrombosis in legs except muscularDay 7 (± 2)Yes/no
Occurrence of proximal asymptomatic deep vein thrombosis in legs by doppler ultrasoundDay 7 (± 2)Yes/no
Occurrence of distal asymptomatic deep vein thrombosis in legs by doppler ultrasoundDay 7 (± 2)Yes/no
Occurrence of muscular asymptomatic deep vein thrombosis in legs by doppler ultrasoundDay 7 (± 2)Yes/no
Occurrence of any kind of asymptomatic deep vein thrombosis except muscular in legs by doppler ultrasoundDay 7 (± 2)Yes/no

Countries

France

Contacts

PRINCIPAL_INVESTIGATOREva Cochery-Nouvellon, Dr

Centre Hospitalier Universitaire de Nīmes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026